Diagnostic reliability of DKK-1, sclerostin, sRANKL, osteopontin and periostin as markers for assessing the myeloma bone disease

被引：0
|
作者：
Gerova, D. [2 ]
Gerov, V. [3 ]
Micheva, I. [3 ]
Galunska, B. [1 ]
机构：
[1] Med Univ Varna, Dept Biochem Mol Med & Nutrigen, Varna, Bulgaria
[2] Med Univ Varna, Dept Clin Lab, Varna, Bulgaria
[3] Med Univ Varna, Haematol, Dept Internal Dis 2, Varna, Bulgaria
来源：
CLINICA CHIMICA ACTA | 2024年 / 558卷
关键词：
D O I：
10.1016/j.cca.2024.119017
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
P1332
引用
收藏
页码：89 / 89
页数：1
相关论文
共 50 条
  • [41] Increased production of DKK-1 in fibrotic cells and osteoblasts in bone from Paget's disease
    McCarthy, Helen
    Mangham, D.
    Davie, Michael
    Marshall, Michael
    BONE, 2010, 46 : S76 - S76
  • [42] A New Anti-Dkk-1 Antibody Targeting Myeloma Bone Disease
    Pozzi, S.
    Yan, H.
    Vallet, S.
    Fulciniti, M.
    Vaghela, N.
    Cirstea, D.
    Santo, L.
    Patel, K.
    Mukherjee, S.
    Hideshima, T.
    Schirtzinger, L.
    Kuhstoss, S.
    Anderson, K. C.
    Scadden, D.
    Raje, N.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S111 - S111
  • [43] DKK-1 and sFRP-3 expression by myeloma cell and bone marrow plasma levels in multiple myeloma and MGUS patients: Potential relationship with bone status.
    Giuliani, Nicola
    Morandi, Francesca
    Tagliaferri, Sara
    Agnelli, Luca
    Todoerti, Katia
    Pedrazzoni, Mario
    Crugnola, Monica
    Deliliers, Giorgio Lambertenghi
    Rizzoli, Vittorio
    Neri, Antonino
    BLOOD, 2006, 108 (11) : 981A - 981A
  • [44] Dkk1 modulates osteoclastogenesis and bone resorption: Implications for myeloma bone disease.
    Oyajobi, BO
    Gupta, A
    Flores, A
    Wideman, C
    Shipman, C
    Mundy, GR
    Garrett, IR
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S32 - S32
  • [45] Dynamics of Bone Disease Biomarkers Dickkopf-1 and Sclerostin in Patients with Multiple Myeloma
    Gerov, Vladimir
    Gerova, Daniela
    Micheva, Ilina
    Nikolova, Miglena
    Mihaylova, Galya
    Galunska, Bistra
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (13)
  • [46] Effect of Recent Spinal Cord Injury on Wnt Signaling Antagonists (Sclerostin and Dkk-1) and Their Relationship With Bone Loss. A 12-Month Prospective Study
    Gifre, Laia
    Vidal, Joan
    Carrasco, Josep L.
    Filella, Xavier
    Ruiz-Gaspa, Silvia
    Muxi, Africa
    Portell, Enric
    Monegal, Ana
    Guanabens, Nuria
    Peris, Pilar
    JOURNAL OF BONE AND MINERAL RESEARCH, 2015, 30 (06) : 1014 - 1021
  • [47] Role of Dickkopf 1 (Dkk1) in myeloma bone disease and modulation by the proteasome inhibitor velcade
    Oyajobi, BO
    Garrett, IR
    Gupta, A
    Banerjee, M
    Esparza, X
    Flores, A
    Rossini, G
    Zhao, M
    Sterling, JA
    Mundy, GR
    CANCER TREATMENT REVIEWS, 2005, 31 : S26 - S27
  • [48] Role of Dickkopf 1 (Dkk) in myeloma bone disease and modulation by the proteasome inhibitor velcade.
    Oyajobi, BO
    Garrett, IR
    Gupta, A
    Banerjee, M
    Esparza, X
    Flores, A
    Sterling, J
    Rossini, G
    Zhao, M
    Mundy, GR
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S4 - S4
  • [49] DKK-1 levels are comparably increased in patients with AS and RA, show similar decreases with anti-TNF therapy, and are not associated with markers of bone remodeling
    Maksymowych, W.
    Malton, C.
    Morrow, S.
    Wang, N.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (04) : 731 - 731
  • [50] DKK-1 levels are comparably increased in patients with AS and RA, show similar decreases with anti-TNF therapy, and are not associated with markers of bone remodeling
    Wang, Nandi
    Mallon, Catherine
    Morrow, Sharon
    Maksymowych, Walter P.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S346 - S346
12345